A detailed history of Dundas Partners LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Dundas Partners LLP holds 70,238 shares of TMO stock, worth $39.3 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
70,238
Previous 69,574 0.95%
Holding current value
$39.3 Million
Previous $40.4 Million 3.94%
% of portfolio
3.01%
Previous 3.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $359,569 - $397,749
664 Added 0.95%
70,238 $38.8 Million
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $3.66 Million - $4.15 Million
6,923 Added 11.05%
69,574 $40.4 Million
Q4 2023

Feb 08, 2024

BUY
$431.41 - $532.94 $382,229 - $472,184
886 Added 1.43%
62,651 $33.3 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $4.22 Million - $4.87 Million
8,477 Added 15.91%
61,765 $31.3 Million
Q1 2023

May 12, 2023

SELL
$535.0 - $604.82 $73,295 - $82,860
-137 Reduced 0.26%
53,288 $30.7 Million
Q4 2022

Feb 08, 2023

BUY
$484.71 - $571.37 $411,518 - $485,093
849 Added 1.61%
53,425 $29.4 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $6.15 Million - $7.56 Million
11,730 Added 28.72%
52,576 $31.1 Million
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $1.3 Million - $1.52 Million
2,278 Added 5.91%
40,846 $23.5 Million
Q2 2019

Aug 01, 2019

BUY
$257.51 - $295.55 $90,128 - $103,442
350 Added 0.92%
38,568 $11.3 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $1.73 Million - $2.05 Million
8,397 Added 28.16%
38,218 $11.9 Million
Q2 2018

Jul 26, 2018

SELL
$203.14 - $219.53 $1.3 Million - $1.41 Million
-6,402 Reduced 17.67%
29,821 $6.19 Million
Q1 2018

Jun 06, 2018

BUY
$192.98 - $224.11 $6.99 Million - $8.12 Million
36,223 New
36,223 $7.1 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $219B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Dundas Partners LLP Portfolio

Follow Dundas Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dundas Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Dundas Partners LLP with notifications on news.